Cogent Biosciences, Inc. (COGT)
NASDAQ · Healthcare
Cogent Biosciences, Inc. Revenue 2017–2020
Cogent Biosciences, Inc. annual/quarterly revenue history and growth rate from 2017 to 2020. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- Cogent Biosciences, Inc. revenue for the quarter ending September 30, 2020 was 312000, a 69.41% decrease year-over-year.
- Cogent Biosciences, Inc. revenue for the twelve months ending September 30, 2020 was 8.9 M, a 10.19% decrease year-over-year.
- Cogent Biosciences, Inc. annual revenue for 2020 was 7.9 M, a 65.02% decrease from 2019.
- Cogent Biosciences, Inc. annual revenue for 2019 was 22.5 M, a 131.14% increase from 2018.
- Cogent Biosciences, Inc. annual revenue for 2018 was 9.7 M, a 16.44% increase from 2017.
- Cogent Biosciences, Inc. annual revenue for 2017 was 8.4 M.
Revenue
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Cogent Biosciences, Inc. Market Cap — FAQ
Cogent Biosciences, Inc. (COGT) market cap over the last 4 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see COGT's market cap history?
The chart and table above show Cogent Biosciences, Inc.'s market cap by year and by quarter, including the growth rate.